ArticleInternational journal of molecular sciences2023

Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells.

Iwona Radziejewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.